Engineered enzymes

US10876102B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10876102-B2
Application numberUS-202016844079-A
CountryUS
Kind codeB2
Filing dateApr 9, 2020
Priority dateOct 22, 2018
Publication dateDec 29, 2020
Grant dateDec 29, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides engineered RNA-guided enzymes for editing live cells.

First claim

Opening claim text (preview).

We claim: 1. A cocktail of engineered nucleic acid-guided nucleases, wherein one or more nucleases in the cocktail has an altered fidelity relative to the nucleic acid-guided nuclease having the sequence of SEQ ID No. 1 and has a sequence comprising any of SEQ ID Nos. 4-7, and wherein one or more nucleases has editing activity in yeast different than the nucleic acid-guided nuclease having the sequence of SEQ ID No. 1 and has a sequence comprising any of SEQ ID Nos. 69-78 or 79-86. 2. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 69. 3. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 70. 4. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 71. 5. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 72. 6. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 73. 7. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 74. 8. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 75. 9. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 76. 10. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 77. 11. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 78. 12. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 79. 13. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 80. 14. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 81. 15. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 82. 16. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 83. 17. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 84. 18. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 85. 19. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 86. 20. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 4. 21. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 5. 22. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 6. 23. The cocktail of engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 7.

Assignees

Inventors

Classifications

  • Stable introduction of foreign DNA into chromosome · CPC title

  • DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) · CPC title

  • C12N9/22Primary

    Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10876102B2 cover?
The present disclosure provides engineered RNA-guided enzymes for editing live cells.
Who is the assignee on this patent?
Inscripta Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).